Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/121509| Title: | Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial |
| Author(s): | Hund, Inga Hess, Maria Elena  Andrieux, Geoffroy Stomper, Julia Greve, Gabriele Niemöller, Christoph Ma, Tobias Uhl, David Grishina, Olga Thol, Felicitas Heuser, Michael |
| Issue Date: | 2025 |
| Type: | Article |
| Language: | English |
| URI: | https://opendata.uni-halle.de//handle/1981185920/123462 http://dx.doi.org/10.25673/121509 |
| Open Access: |  Open access publication |
| License: |  (CC BY 4.0) Creative Commons Attribution 4.0 |
| Journal Title: | Leukemia |
| Publisher: | Springer Nature |
| Publisher Place: | London |
| Volume: | 39 |
| Issue: | 11 |
| Original Publication: | 10.1038/s41375-025-02780-7 |
| Page Start: | 2816 |
| Page End: | 2819 |
| Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| s41375-025-02780-7.pdf | 1.48 MB | Adobe PDF |  View/Open |